Welcome to GENESIS Hangzhou!

page_banner

news

This kit is designed for testing freshly collected saliva samples.

COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

To make the test more convenient, we Genesis launch the KaiBiLi COVID-19 saliva antigen test. The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immuno-chromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in saliva. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.

Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.

Patients with negative result should be treated as presumptive. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be confirmed with a molecular assay, if necessary, for patient management.

The KaiBiLiTM COVID-19 Antigen Rapid Test was compared with a leading commercial PCR; the results show that KaiBiLiTM COVID-19 Antigen Rapid Test has a high sensitivity and specificity.

 

 

PCR

 

 

Total

KaiBiLiTM 

COVID-19 Antigen

111

3

114

4

136

140

Total

115

139

254

Positive Percent Agreement:96.5% (95%CI:91.3%-99.0%) 

Negative Percent Agreement:97.8% (95%CI:93.8%-99.6%)

Overall Percent Agreement:97.2%(95%CI:94.4%-98.9%)

GENESIS YOUR TRUSTABLE PARTNER FOR RAPID TESTING


Post time: Jul-19-2021